Molecular Medicine

, Volume 12, Issue 11–12, pp 291–299 | Cite as

Glucocorticoids and TNFα Interact Cooperatively to Mediate Sepsis-Induced Leucine Resistance in Skeletal Muscle

  • Charles H LangEmail author
  • Robert A Frost
Research Article


Sepsis blunts the ability of nutrient signaling by leucine to stimulate skeletal muscle protein synthesis by impairing translation initiation. The present study tested the hypothesis that overproduction of either tumor necrosis factor (TNF)-α or glucocorticoids mediate the sepsis-induced leucine resistance. Prior to producing peritonitis, rats received either vehicle, TNF binding protein (TNFBP) to inhibit endogenous TNFα action, and/or the glucocorticoid receptor antagonist RU486. Leucine was orally administered to all rats 24 h thereafter and the gastrocnemius removed 20 min later to assess protein synthesis and signaling components important in controlling peptide-chain initiation. Muscle protein synthesis was 65% lower in septic rats administered leucine than in leucine-treated control animals. This reduction was not prevented by either TNFBP or RU486 alone, but was completely reversed by the combination. This sepsis-induced leucine resistance was associated with an 80% reduction in the amount of active eIF4E·eIF4G complex, a 5-fold increase in the formation of the inactive eIF4E·4E-BP1 complex as well as markedly reduced (at least 70%) phosphorylation of 4E-BP1, eIF4G, S6K1, S6, and mTOR. Pretreatment of septic rats with either TNFBP or RU486 individually only nominally improved the leucine action as assessed by the above-mentioned endpoints. In contrast, when TNFBP and RU486 were co-administered, the ability of sepsis to impair the leucine-stimulated phosphorylation of 4E-BP1, eIF4G, S6K1, and S6 as well as the redistribution of eIF4E was essentially prevented. No differences in the total amount or phosphorylation of eIF2α and eIF2Bε were detected between the different groups, and changes could not be attributed to differences in the prevailing plasma concentration of insulin or leucine. Our data demonstrate the sepsis-induced leucine resistance in skeletal muscle results from the cooperative interaction of both TNFα and glucocorticoids.



This work was supported in part by NIH grant GM38032. We thank Anne Pruznak and Nobuko Deshpande for their expert technical assistance.


  1. 1.
    Jefferson LS, and Kimball SR. (2001) Amino acid regulation of gene expression. J. Nutr. 2001:131, 9Suppl:2460–8S.CrossRefGoogle Scholar
  2. 2.
    Anthony JC, Yoshizawa F, Anthony TG, Vary TC, Jefferson LS, and Kimball SR. (2000) Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J. Nutr. 130:2413–9.CrossRefGoogle Scholar
  3. 3.
    Buse MG and Reid SS. (1975) Leucine: a possible regulator of protein turnover in muscle. J. Clin. Invest. 56:1250–61.CrossRefGoogle Scholar
  4. 4.
    Jurasinski C, Gray K, and Vary TC. (1995) Modulation of skeletal muscle protein synthesis by amino acids and insulin during sepsis. Metabolism 44:1130–8.CrossRefGoogle Scholar
  5. 5.
    Kimball SR, Shantz, LM, Horetsky RL, and Jefferson LS. (1999) Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6. J. Biol. Chem. 274:11647–52.CrossRefGoogle Scholar
  6. 6.
    Dardevet D, Sornet C, Balage M, and Grizard J. (2000) Stimulation of in vitro rat muscle protein synthesis by leucine decreases with age. J. Nutr. 130:2630–5.CrossRefGoogle Scholar
  7. 7.
    Li JB, and Jefferson LS. (1978) Influence of amino acid availability on protein turnover in perfused skeletal muscle. Biochim. Biophys. Acta. 544:351–9.CrossRefGoogle Scholar
  8. 8.
    May ME, and Buse MG. (1989) Effects of branched-chain amino acids on protein turnover. Diabetes Metab. Rev. 5:227–45.CrossRefGoogle Scholar
  9. 9.
    Hara K, Kazuyoshi K, Weng Q-P, Kozlowski MT, Belha G, and Avruch J. (1998) Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J. Biol. Chem. 273:14484–94.CrossRefGoogle Scholar
  10. 10.
    Avruch J, Belham C, Weng Z, Hara K, and Yonezawa K. (2001) The p70 S6 kinase integrates nutrient and growth signals to control translational capacity. Prog. Mol. Subcell. Biol. 26:115–54.CrossRefGoogle Scholar
  11. 11.
    Gingras A-C, Raught B, and Sonenberg N. (2001) Regulation of translation initiation by FRAP/TOR. Genes Dev. 15:807–26.CrossRefGoogle Scholar
  12. 12.
    Duncan R, Milburn SC, and Hershey JW. (1987) Regulated phosphorylation and low abundance of HeLa cell initiation factor 4F suggest a role in translational control. Heat shock effect on eIF-4F. J. Biol. Chem. 262:380–8.PubMedGoogle Scholar
  13. 13.
    Hara K, Yonezawa K, Kozlowski MT, Sugimoto T, Andrabi K, Weng QP, Kasuga M, Nishimoto I, and Avruch J. (1997) Regulation of eIF-4E BP1 phosphorylation by mTOR. J. Biol. Chem. 272:26457–63.CrossRefGoogle Scholar
  14. 14.
    Kawasome H, Papst P, Webb S, Keller GM, Johnson GL, Gelfand EW, and Terada N. (1998) Targeted disruption of p70 S6K defines its role in protein synthesis and rapamycin sensitivity. Proc. Natl. Acad. Sci. USA 95:5030–8.CrossRefGoogle Scholar
  15. 15.
    Lang CH, and Frost RA. (2004) Differential effect of sepsis on ability of leucine and IGF-I to stimulate muscle translation initiation. Am. J. Physiol. Endocrinol. Metab. 287:E721–30.CrossRefGoogle Scholar
  16. 16.
    Rennie MJ. (1985) Muscle protein turnover and the wasting due to injury and disease. Br. Med. Bull. 41:257–64.CrossRefGoogle Scholar
  17. 17.
    Vary TC, Owens EL, Beers JK, Verner K, and Cooney RN. (1996) Sepsis inhibits synthesis of myofibrillar and sarcoplasmic proteins: modulation by interleukin-1 receptor antagonist. Shock 6:13–8.CrossRefGoogle Scholar
  18. 18.
    Zamir O, Hasselgren PO, von Allmen D, and Fischer JE. (1991) The effect interleukin-1α and the glucocorticoid receptor blocker RU 38486 on total and myofibrillar protein breakdown in skeletal muscle. J. Surg. Res. 50:579–83.CrossRefGoogle Scholar
  19. 19.
    Lang CH, Frost RA, Jefferson LS, Kimball SR, and Vary TC. (2000) Endotoxin-induced decrease in muscle protein synthesis is associated with changes in eIF2B, eIF4E, and IGF-I. Am. J. Physiol Endocrinol. Metab. 278:E1133–43.CrossRefGoogle Scholar
  20. 20.
    Lang CH, Frost RA, Nairn AC, MacLean DA, and Vary TC. (2002) TNFα_impairs heart and skeletal muscle protein synthesis by altering translation initiation. Am. J. Physiol Endocrinol Metab. 282:E336–47.CrossRefGoogle Scholar
  21. 21.
    Shah OJ, Kimball SR, and Jefferson LS. (2000) Acute attenuation of translation initiation and protein synthesis by glucocorticoids in skeletal muscle. Am. J. Physiol Endocrinol Metab. 278: E76–82.CrossRefGoogle Scholar
  22. 22.
    Rieu I, Sornet C, Brizard J, and Dardevet D. (2004) Glucocorticoid excess induces a prolonged leucine resistance on muscle protein synthesis in old rats. Exp. Geront. 39:1315–21.CrossRefGoogle Scholar
  23. 23.
    Lang CH, and Frost RA. (2005) Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle. J. Cell. Physiol. 203:144–55.CrossRefGoogle Scholar
  24. 24.
    Crozier SJ, Kimball SR, Emmert SW, Anthony JC, and Jefferson LS. (2005) Oral leucine administration stimulate protein synthesis in rat skeletal muscle. J. Nutr. 135:376–82.CrossRefGoogle Scholar
  25. 25.
    Vary TC, and Lynch CJ. (2006) Meal feeding enhances formation of eIF4F in skeletal muscle: role of increased eIF4E availability and eIF4G phosphorylation. Am. J. Physiol. Endocrinol. Metab. 290:E631–42.CrossRefGoogle Scholar
  26. 26.
    Lang CH, Krawiec BJ, Huber D, McCoy JM, and Frost RA. (2006) Sepsis and inflammatory insults downregulate IGFBP-5, but not IGFBP-4, in skeletal muscle via a TNF-dependent mechanism. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290:R963–72.CrossRefGoogle Scholar
  27. 27.
    Espat NJ, et al. (1995) PEG-BP-30 monotherapy attenuates the cytokine-mediated inflammatory cascade in baboon Escherichia coli septic shock. J. Surg. Res. 59:153–8.CrossRefGoogle Scholar
  28. 28.
    Lang CH, Pruznak AM, and Frost RA. (2005) TNFα mediates sepsis-induced impairment of basal and leucine-stimulated signaling via S6K1 and eIF4E in cardiac muscle. J. Cell. Biochem. 94:419–31.CrossRefGoogle Scholar
  29. 29.
    Frost RA, Nystrom GJ, Jefferson LS, and Lang CH. (2007) Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. (in press).Google Scholar
  30. 30.
    Li YH, Fan J, and Lang CH. (1997) Role of glucocorticoids in mediating endotoxin-induced changes in IGF-I and IGF binding protein-1. Am. J. Physiol. Regulatory, Integrative Comp. Physiol. 272:R1990–7.CrossRefGoogle Scholar
  31. 31.
    Gingras AC, Raught B, Gygi SP, Niedzwiecka A, Miron M, Burley SK, Polakiewicz RD, Wyslouch-Cieszynska A, Aebersold R, and Sonenberg N. (2001) Hierarchical phosphorylation of the translational inhibitor 4E-BP1 Genes Devel. 15:2852–64.CrossRefGoogle Scholar
  32. 32.
    Raught B, Gingras AC, Gygi SP, Imatake H, Morino S, Gradi A, Aebersold R, and Sonenberg N. (2000) Serum-stimulated rapamycin-sensitive phosphorylation sites in the eukaryotic translation initiation factor 4G1. EMBOJ 19:434–44.CrossRefGoogle Scholar
  33. 33.
    Weng QP, Kozlowski M, Belham C, Zhang A, Comb MJ, and Avruch J. (1998) Regulation of the p70 S6 kinase by phosphorylation in vivo. Analysis using site-specific anti-phosphopeptide antibodies. J. Biol. Chem. 273:16621–9.CrossRefGoogle Scholar
  34. 34.
    Pain VM. Initiation of protein synthesis in mammalian cells. (1986) Biochem. J. 235:625–37.CrossRefGoogle Scholar
  35. 35.
    Gamrin L, Essen P, Forsberg AM, Hultman E, and Wernerman J. A. (1996) Descriptive study of skeletal muscle metabolism in critically ill patients: free amino acids, energy-rich phosphates, protein, nucleic acids, fat, water and electrolytes. Crit. Care Med. 24:575–83.CrossRefGoogle Scholar
  36. 36.
    Cooney R, Kimball SR, Eckman R, Maish G, Shumate M, and Vary TC. (1999) TNF-binding protein ameliorates inhibition of skeletal muscle protein synthesis during sepsis. Am. J. Physiol. Endocrinol. Metab. 276:E611–9.CrossRefGoogle Scholar
  37. 37.
    Breuille D, Voisin L, Contrepois M, Arnal M, Rose F, and Obled C.A. (1999) Sustained rat model for studying the long-lasting catabolic state of sepsis. Infect. Immun. 67:1079–85.PubMedPubMedCentralGoogle Scholar
  38. 38.
    Zamir O, Hasselgren PO, Kunkel SL, Frederick J, Higashiguchi T, and Fischer JE. (1992) Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch. Surg. 127:170–4.CrossRefGoogle Scholar
  39. 39.
    Sapolsky RM, Romero LM, and Munck AU. (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrine Rev. 21:55–89.Google Scholar
  40. 40.
    Penner CG, Gang G, Wray C, Fischer JE, and Hasselgren PO. (2001) The transcription factors NF-κB and AP-1 are differentially regulated in skeletal muscle during sepsis. Biochem. Biophys. Res. Commun. 281:1331–6.CrossRefGoogle Scholar
  41. 41.
    Zawacki JK, Hunt JL, Gamelli RL, and Filkins, JP. (1997) Glucocorticoid regulation of hepatic TNF production following cecal ligation and puncture sepsis. Shock 8:141–5.CrossRefGoogle Scholar
  42. 42.
    Hawes AS, Rock CS, Keogh CV, Lowry SF, and Calvano SE. (1992) In vivo effects of the antiglucocorticoid Ru486 on glucocorticoid and cytokine responses to Escherichia coli endotoxin. Infection Immunity 60:2641–7.PubMedGoogle Scholar
  43. 43.
    Bertini R, Bianchi M, and Ghezzi P. (1988) Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J. Exp. Med. 167:1708–12.CrossRefGoogle Scholar
  44. 44.
    Munck A, and Naray-Fejes-Toth A. (1992) The ups and downs of glucocorticoid physiology. Permissive and suppressive effects revisited. Molec. Cell. Endocrin. 90:C1–C4.CrossRefGoogle Scholar
  45. 45.
    Davies AO, and Lefkowitz RJ. (1984) Regulation of beta-adrenergic receptors by steroid hormones. Ann. Rev. Physiol. 46:119–30.CrossRefGoogle Scholar
  46. 46.
    Barber AE, et al. (1993) Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J. Immunol. 150:1999–2006.PubMedGoogle Scholar
  47. 47.
    Hermoso M, Matsuguchi T, Smoak K, and Cidlowski JA. (2004) Glucocorticoids and tumor necrosis factor alpha cooperatively regulate tolllike receptor 2 gene expression. Molec. Cell. Biol. 24:4743–56.CrossRefGoogle Scholar
  48. 48.
    Snyers L, De Wit L, and Content J. (1990) Glucocorticoid up-regulation of high-affinity interleukin-6 receptors on human epithelial cells. Proc. Natl. Acad. Sci. USA 87:2838–42.CrossRefGoogle Scholar
  49. 49.
    Jensen LE, and Whitehead AS. (1998) Regulation of serum amyloid A protein expression during the acute-phase response. Biochem. J. 334:489–503.CrossRefGoogle Scholar
  50. 50.
    Sun X, Fischer DR, Pritts TA, Wray CJ, and Hasselgren PO. (2002) Expression and binding activity of the glucocorticoid receptor are upregulated in septic muscle. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 282:R509–18.CrossRefGoogle Scholar
  51. 51.
    Suzuki S, et al. (2005) Inflammatory mediators down-regulate 11β-hydroxysteroid dehydrogenase type 2 in human lung epithelial cell line BEAS-2B and the rat lung. Tohoku J. Exp. Med. 207:293–301.CrossRefGoogle Scholar
  52. 52.
    Cai TQ, Wong B, Mundt SS, Thieringer R, Wright SD, and Hermanowksi-Vosatka A. (2001) Induction of 11β-hydroxysteroid dehydrogenase type 1 but not -2 in human aortic smooth muscle cells by inflammatory stimuli. J. Steroid Biochem. Molec. Biol. 77:117–22.CrossRefGoogle Scholar
  53. 53.
    Almawi WY, Beyhum HN, Rahme AA, and Rieder MJ. (1996) Regulation of cytokine and cytokine receptor expression by glucocorticoids. J. Leukoc. Biol. 60:563–72.CrossRefGoogle Scholar
  54. 54.
    Wiegers GJ, and Reul JMHM. (1998) Induction of cytokine receptors by glucocorticoids: functional and pathological significance. Tips 19:317–21.PubMedGoogle Scholar

Copyright information

© Feinstein Institute for Medical Research 2006

Authors and Affiliations

  1. 1.Department of Cellular & Molecular Physiology, and SurgeryPennsylvania State University College of MedicineHersheyUSA

Personalised recommendations